Neuraxis Inc.(NYSE MKT:NRXS) 
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare ...
Website: https://neuraxis.com/
Founded: 2011
IPO Price: $6 (Aug 09, 2023)
Full Time Employees: 17
Sector: Biotechnology
Industry: Healthcare
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.14
H 2.21
L 1.69
C 2.00
V 68,572
10EMA 2.00
20EMA 2.00
60EMA 2.00
120EMA 2.00
250EMA 2.00